Does accreditation improve pro re nata benzodiazepines administration in psychiatric inpatients? Pre-post accreditation medical record comparison by Mohammed Abdullah Al-Sughayir
Al‑Sughayir  Int J Ment Health Syst  (2017) 11:16 
DOI 10.1186/s13033‑017‑0124‑8
RESEARCH
Does accreditation improve pro re nata 
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Background: In psychiatric inpatients, administration of pro re nata benzodiazepines is a common practice. Benzo‑
diazepine use is associated with potential complications of risk of abuse, cognitive impairment, and falls. An interest 
in accreditation is growing rapidly among many countries to enhance the quality of health care services. We aimed 
to investigate whether hospital accreditation drives improvements for administered pro re nata benzodiazepines in 
psychiatric inpatients.
Methods: The study reviewed medical records of consecutive hospital admissions for pre‑ and post‑accreditation 
comparisons of PRN benzodiazepine medications in two acute mental health wards at a teaching general hospital. 
Data obtained from the 12‑month‑post‑accreditation period (July 2011–June 2012) were compared with those from 
the 12‑month‑pre‑accreditation period (July 2009–June 2010). The adoption of accreditation standards occurred over 
a 12‑month period in the middle of the study (July 2010–June 2011). Compiled information included demographics, 
diagnosis, assessment, and LOS. All identified charts were reviewed; there were no exclusion criteria. Patients were not 
contacted.
Results: There was a statistically significant (P < 0.002) reduction of approximately 22% in the number of adminis‑
tered PRN benzodiazepines. Post‑accreditation, the average number of PRN benzodiazepines administrations per 
patient, was 4.83 ± 2.1 compared to 6.19 ± 3.4 pre‑accreditation. There was no significant difference between the 
two genders. The highest average quantity of PRN benzodiazepines administered was during the time interval of 
18–24 h.
Conclusion: Accreditation may have a positive impact on the process of administering PRN benzodiazepine medica‑
tions in psychiatric inpatients.
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Background
Benzodiazepines (BDZs) were developed in 1962 as a 
treatment for anxiety symptoms. Because of rapid tran-
quilizing effect, BDZs are commonly used for the con-
trol of agitation, disruptive behavior, and insomnia in 
psychiatric inpatients [1]. More recently there has been 
a shift away from using the sedative side-effects of antip-
sychotics to using benzodiazepines that sedate with 
minimal side-effect risks [2]. Benzodiazepines such as 
lorazepam are recommended as the drugs of first choice 
when rapid tranquillization is required because of their 
sedative effects [3]. However, benzodiazepine use is also 
associated with potential complications of tolerance, 
dependence and withdrawal symptoms, risk of abuse 
and cognitive impairment [2]. Dependence can develop 
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of regular usage, but it may develop more rapidly to very 
high doses administered for a shorter period of time or in 
the case of individuals who have been previously depend-
ent on other sedatives or alcohol [4]. Despite guideline 
precautions, long‐term prescription of BZDs is still a 
common treatment pattern [5, 6]. Clinicians’ over pre-
scriptions of BZDs may result in abuse problems [7].
The present study focused on BDZ medications 
because their clinical relevance to psychiatric inpatients. 
There are many adverse effects of BDZs on psychiatric 
inpatients including cognitive impairment, delirium, psy-
chomotor slowing, risk of respiratory distress, overseda-
tion, falls and hip fractures [8, 9].
Interest in accreditation of health care organization 
(HCOs) is growing rapidly among developing coun-
tries [10]. Saudi Arabia was one of the first countries in 
the eastern Mediterranean region to implement health 
care accreditation standards [11]. Several governmental 
hospitals in Saudi Arabia have received accreditation 
from different international accreditation bodies [12]. 
King Khalid University Hospital (KKUH) in Riyadh, the 
site of the study, obtained two cycles of accreditation 
from Accreditation Canada International (ACI). The 
first was in February 2011, and the second was in May 
2014. The ACI is a non-governmental quality organi-
zation that offers health care improvement services 
worldwide.
In psychiatric inpatient services, administration of 
pro re nata (PRN, or ‘as required’) psychotropic medi-
cation is a common practice. The rate of administered 
PRN medications to patients in psychiatric units in the 
United States of America is 35%, Canada 50%, Britain 
50% and Australia 80% [13, 14]. On admission, about 
75% of mental health patients were routinely prescribed 
PRN medications [15]. Unnecessary reliance on PRN 
psychotropic medications for psychiatric inpatients can 
undermine the quality of care. To ensure efficient care 
in inpatient psychiatric services, standardized practice 
guidelines for PRN medications are essential. The clini-
cal practice guidelines for PRN medications eliminate 
differences in implementation and reduce a medication-
related morbidity, which is strongly associated with PRN 
medications.
Pro re nata BDZ medications is important and under-
researched clinical intervention used in psychiatric 
wards. Little is known about the effect of the accredita-
tion process on PRN benzodiazepine medications in 
psychiatric inpatients. Prescribing PRN benzodiazepine 
medications in psychiatric inpatients in Saudi Ara-
bia have never been reported [16, 17]. Thus, this study 
attempted to investigate whether hospital accreditation 
drives improvement of administering PRN benzodiaz-
epine medications for psychiatric inpatient care.
Methods
Design
The study reviewed medical records of consecutive hos-
pital admissions for pre- and post-accreditation compari-
sons of PRN benzodiazepine medications in two acute 
mental health wards.
Site
The inpatient psychiatric units at King Khalid University 
Hospital (KKUH) in Riyadh, Saudi Arabia, which is the 
only public teaching hospital in Riyadh City with an 800-
bed capacity. The psychiatric units comprise 22 mental 
health beds (11 for each sex) in locked-door wards, and 
adequately staffed with psychologists and social work-
ers along with medical and nursing personnel. Patient 
admissions are usually through the emergency depart-
ment, outpatient clinics, and rarely from medical wards. 
Hospitalization includes stabilization of crisis presenta-
tions, planned diagnostic assessments, and brief intensive 
treatment.
Subjects
Psychiatric inpatients admitted during the 12-month-
post-accreditation period (July 2011–June 2012) were 
compared with those from the 12-month-pre-accredita-
tion period (July 2009–June 2010). All identified charts 
were eligible for review including patients leaving against 
medical advice; there were no exclusion criteria. How-
ever, to maintain independence of observations, only the 
first hospitalization per patient during the study period 
was included and the charts of patients who were read-
mitted during the study period (three patients in the pre-
accreditation and two patients in the post-accreditation 
periods) were excluded. Patients were not contacted.
Data collection
A structured data collection sheet has been made includ-
ing the following factors for each patient demographics, 
diagnosis, assessment, and administered PRN benzodiaz-
epine medications. The psychiatric inpatient case regis-
ter in each unit was accessed to identify all administered 
PRN benzodiazepine medications to in-patients admitted 
during the two study periods. Data in the case register are 
recorded by nursing staff under the direct supervision of 
an expert head nurse. After patient’s discharge, the medi-
cal file is forwarded to the Medical Record Department 
at KKUH. Clinical data were extracted in October 2012 
by the author from patients’ files at the Medical Record 
Department. Data were paper record-based information. 
The quality of data records was identified and assessed 
based on the availability and legibility of a detailed docu-
mentation for all admissions in both study periods. The 
psychiatric nurses, under the supervision of the unit 
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head nurse, recorded the required data in legible Eng-
lish. The data were then coded and entered into statistical 
software.
Intervention
The accreditation process, which is a system of strategic 
planning to promote the quality of the clinical practice. 
The accreditation program included 18 mental health 
standards focusing on patients’ safety, a recommendation 
to adopt clinical practice guidelines for PRN medications 
(Table 1), biopsychosocial multidisciplinary team (MDT) 
approach with an objective assessment of symptoms 
severity through the Brief Psychiatric Rating Scale (BPRS), 
rapid evaluation, and clear discharge plan. The standards 
incorporated the Plan-Do-Check-Act circle. The adop-
tion of accreditation program occurred over a 12-month 
period (July 2010–June 2011) in the middle of the study. 
A team of surveyors examined hospital’s compliance with 
the Accreditation Canada International standards dur-
ing an onsite survey. Hospital performance was assessed 
based on reviewing guidelines, interviewing staff, and 
conducting tracers. Based on these findings, the hospital 
as a whole was awarded accreditation in February 2011.
Analysis
The collected data were entered into a spreadsheet for 
analysis. Statistical analysis was conducted using Sta-
tistical Package for the Social Science (SPSS) version 15 
software for Windows (SPSS Inc., Chicago, IL, USA). 
The Mann–Whitney test was used to compare the means 
from 2 independent groups. A P value of <0.05 indicated 
statistical significance.
Results
There were 182 patients, during the post-accreditation 
period, compared to 177 patients during the pre-accred-
itation period. Table 2 shows the socio-demographic and 
clinical characteristics of the study populations for the 
two study periods. There were no statistically significant 
differences (P > 0.05; for all comparisons).
Post-accreditation, the average number of PRN ben-
zodiazepines administrations per patient, was 4.83 ± 2.1 
compared to 6.19  ±  3.4 pre-accreditation. There was a 
statistically significant (P < 0.002) reduction of approxi-
mately 22% in the number of administered PRN benzodi-
azepines. There was no significant difference between the 
two genders.
The average quantity of PRN benzodiazepines adminis-
tered in each 6-h interval during the day, throughout the 
whole period of admission, was also investigated for the 
two study periods. The highest average quantity of PRN 
benzodiazepines administered was during the time inter-
val of 18–24 h (Table 3).
In both study periods, lorazepam was administered 
most often followed by diazepam.
The most common reported reasons for administration 
of PRN benzodiazepines in both study periods were agi-
tation, insomnia, and aggression.
Table 1 The clinical practise for  the guidelines for  the 
administration of PRN psychotropic applied at KKUH psy-
chiatric in patientsa
a With permission from Phychiatry Department, College of Medicine,  KSU
After patient admission, all current medications should be documented 
and reciewed by the admitting team for medication reconciliation
 Use of regular medications for individual patients as PRN is always 
recommended. Polypharmacy is discouraged
 When handling a patient’s difficult behaviour, before resorting to PRN 
medications, alternative interventions (e.g., counseling) should be 
attempted
For each patient, the treating psychiatrist should complete the medication 
orders with the required regimen of PRN medication as soon as possible
 Patient accepting oral PRN medications and appropriately responding to 
it should not be given an injection
Administered PRN medication and its response should be clearly docu‑
mented
After administered PRN medications, the nurse in charge should monitor 
the vital signs at least hourly and watch for extrapyramidal side effects
If the nurse has any concern, he/she should immediately inform the treat‑
ing phychiatrist and ask for a medical evaluation
Table 2 Comparison between  the demographic and  clini-
cal characteristics of pre- and post-accreditation patients
a Level of statistical significance is 5%








 Male 82 (46.3) 84 (46.2) 0.999
 Female 95 (53.7) 98 (53.8)
Age (years)
 <25 50 (28.2) 59 (32.4) 0.590
 25–50 104 (58.8) 104 (57.1)
 >50 23 (13.0) 19 (10.5)
Marital status
 Single 98 (55.4) 112 (61.5) 0.352
 Divorced/separated 20 (11.3) 22 (12.1)
 Married 59 (33.3) 48 (26.4)
Diagnosis
 Organic mental disorders 6 (3.4) 11 (6.0) 0.089
 Non‑affective psychosis 78 (44.1) 61 (33.5)
 Affective psychosis 73 (41.2) 94 (51.6)
 Others disorders 20 (11.3) 16 (8.8)
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Discussion
Accreditation of health care organizations encour-
ages achieving and validating a high quality of patients’ 
care. The present study focused on the actually admin-
istered rather than on the prescription pattern of PRN 
benzodiazepines.
The socio-demographic and clinical characteristics of 
the study populations for the two study periods appear to 
have no confounding effects in the present study, as there 
were no statistically significant differences for all com-
parisons. However, research has shown that psychiatric 
diagnosis has a limited influence on PRN administration. 
The main factors that affect the use of PRN medications 
in psychiatric inpatients are the severity of behavioral 
disturbances, the availability of alternative interventions, 
the ward environment, and nursing staff characteristics 
rather than the diagnosis [18].
There was no change in the number of nursing staff at 
KKUH psychiatric wards in the two study periods.
The reported means of PRN medications in psychiatric 
inpatients in the international studies were 10–12 admin-
istrations per patient [19, 20]. In the present study, the 
average number of PRN benzodiazepines administrations 
per patient post-accreditation was 4.83 ±  2.1 compared 
to 6.19 ±  3.4 PRN benzodiazepines administrations per 
patient before accreditation. There is a reassuring sig-
nificant reduction of approximately 22% in the num-
ber of administered PRN benzodiazepines per patient. 
This reduction can be explained by many collaborating 
factors. First, the positive effect of the clinical practice 
guidelines for the administration of PRN psychotropic 
medications at KKUH psychiatric inpatient units. Sec-
ond, the role of the biopsychosocial multidisciplinary 
management approach. Third, the participation of a clini-
cal pharmacist in the regular review of patients’ treat-
ment to ensure appropriateness of ongoing prescribed 
medication regimens and in the education of nursing 
staff regarding medication choice and alternative treat-
ment options. Fourth, nurses perceived the accredita-
tion and the clinical practice guidelines favorably. Before 
resorting to PRN medications, nurses were encouraged to 
utilize a positive nurse-patient relationship and to apply 
non-pharmacological alternative interventions like face-
to-face de-escalation and supportive contacts. However, 
the content of such interventions is difficult to validate. 
Further investigation is required to explore the successful 
factors embedded in the alternative interventions.
It would have been better if the study had investigated 
the rates of seclusion and restraints to know whether 
there had been an accompanying increase in the alterna-
tive methods of inpatients containment. However, some 
researchers found that while the rate of administered 
PRN medications decreased significantly, there was no 
accompanying increase in the other methods of inpa-
tients containment; seclusion and restraint [21].
In concordance with previous studies [19, 22], of the 
PRN benzodiazepines in this study, lorazepam was 
administered most often in both study periods.
The most common reported reasons for the adminis-
tration of PRN benzodiazepines in this study were agi-
tation, insomnia, and aggression. This is consistent with 
previous studies [23, 24].
The average quantity of PRN benzodiazepines admin-
istered per patient between 18:00 and 24:00  h was five 
in the pre-accreditation period, and it was reduced to 
3.3 during the post-accreditation period. In accordance 
with previous studies [24, 25], the most common time 
for a PRN benzodiazepine medication to be administered 
was between 18:00 and 24:00  h. This time of the day is 
consistent with settling patients at bedtime because sleep 
disturbances are often present in acute mental illness. 
This temporal pattern of PRN sedation allows an oppor-
tunity for initiating behavioral interventions to reduce 
the need for unnecessary PRN benzodiazepines.
The study has certain limitations that should be con-
sidered. It represents data for only one center with an 
inherent selection bias. It is a record-based retrospec-
tive study with questions on the reliability of documen-
tation. However, the initial information of this study can 
provide a view regarding accreditation effect on medical 
practice in KSA, which may assist in the future planning 
of psychiatric services in the country. In KSA, national 
standard practice guidelines to the use of PRN medica-
tions in mental health services should be established and 
implemented.
To support the findings of this study, multicenter 
research with a larger sample size is substantially needed. 
Future studies need to focus on the impact of quality 
measures on prescriber characteristics, whether BDZs 
were discontinued before discharge and the duration of 
BDZs after discharge.
In conclusion, findings indicate that hospital accredi-
tation may have a positive impact on the process of 
Table 3 Comparisons of  the average number of  tablets 
of  PRN benzodiazepines administered every 6-h intervals 
throughout the day
a Statistically significant at 5% level of significance
Timing
(24 h)
Study period P value
Pre-accreditation Post-accreditation
000–0600 2.41 ± 1.2 (70) 1.85 ± 1.0 (66) 0.003a
0600–1200 None 1.44 ± 0.5 (16) N. A.
1200–1800 2.0 ± 0.8 (4) 1.60 ± 0.6 (50) 0.263
1800–2400 5.05 ± 2.4 (128) 3.30 ± 1.4 (152) <0.001a
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administering PRN benzodiazepine medications in psy-
chiatric inpatients.
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